DOI:

EAPCI: update on subspecialty accreditation in Europe

William Wijns*, President EAPCI

In our last two columns we spoke about the basis of our association, its history and general goals, in this article we update the situation concerning the EAPCI and its involvement in the nuts-and-bolts discussions that are laying the groundwork for subspecialty education and accreditation in Europe today.

Within Europe there are two primary boards working towards the accreditation, harmonisation and coordination of cardiology education and training. In education, it is the European Board for Accreditation in Cardiology (EBAC) which offers an “independent professional peer delivered accreditation of educational events and products” recognised by 19 national professional medical societies within Europe. In training, the EACPI is an active member of the European Board for the Specialty of Cardiology (EBSC) Coordination Task Force on Sub-specialty Accreditation. This task force was created in 2004, and is chaired by Jose Lopez-Sendon and Peter Mills, the EAPCI is represented by Carlo Di Mario. The EBSC itself was created in 1992 by the Union Européenne des Médecins Spécialistes – Cardiology Section (UEMS - CS), in cooperation with the European Society of Cardiology (ESC) in order to set the “standards of care” for European cardiology. Its role is to make recommendations for setting and maintaining the standards of training in terms of quality, content, institutions and the trainers themselves. It evaluates member states and works towards the harmonisation of EC standards in cardiology. The EBSC created the current task force in order to, “define and promote sub-specialty accreditation standards, requirements and procedures… and contribute to the overall coherence of accreditation within the specialty of Cardiology”. This task force acts in several ways: as a coordinating body for training accreditation support within associations and Working Groups in the ESC; in implementing accreditation; and working with national societies to anticipate and influence regulation. The task force becomes a point-of-reference for the varied subspecialties as they work towards devising a common curricular template, developing common assessment methods and increasing awareness of European subspecialty accreditation development.

As you are perhaps aware, in Europe today the majority of countries offer apprenticeship, but no real certification subspecialty accreditation, and very few have any formal accredited training and recognised certification programmes. Peter Mills (see figure 1) speaking at the last EuroPCR, explained that the principles of accreditation must be readily acceptable throughout the community as well as being fully integrated, with a growing need to “complement the ESC core curriculum”.

Figure 1. EBSC proposed outline for assessment framework.

A curriculum is now emerging through the experience of EAPCI members which aims to do this, assessing knowledge, skills and professionalism. Assessment methods are being debated, including the use of a European portfolio – or “e-logbook” – used to analyse the case mix that an aspiring interventionalist performs. Ideally a system will be put in place that assesses in a clear, comparable and repeatable fashion “intellectual development” with “direct observation of practical skills” that would demonstrate competence for the physician in such areas as patient selection, alternative clinical options or pre- and post- procedural care, etc.

The standardisation of accreditation in interventional medicine cannot simply apply to the curriculum itself, but touches on the role of the exam or knowledge assessment. There is a continuing discussion over “summative or formative” knowledge, taking into account that “learning should be part of assessment” and that the “most serious deficiencies in practice are not due to lack of knowledge”.

An effective training programme, training centre and trainer need to be defined. The emerging potential for simulators and virtual reality as training and assessment tools also needs to be quantified and qualified; their legitimacy depends on the development of a separate and recognised standard. To this end, an ongoing dialogue with industry has been developed, an essential cooperation allowing for “liaising with industry based programmes” and special industry sessions, requiring a neutral and accepted evaluation method to insure the independence of each programme. Four companies have already agreed to work together toward helping define these standards.

Much has been accomplished, but much more needs to be put into place before a complete European system of subspecialty accreditation exists. CME credits, professional certification with European-wide and international recognition, harmonisation of standards and quality-of-care are the ongoing goals, and the EAPCI will take the lead in this process as the details and necessary components make themselves known.

As Peter Mills concluded in his remarks, there is a “strength” in “sound educational principles” and cardiology “must play a leadership role” in a Europe that “represents authority and quality, arising from expert consensus across countries and subspecialties, e.g., ESC guidelines”. And as you all can well understand from the above, there is much more to come from your Association about this programme in the near future as it continues to evolve and take shape.

Volume 3 Number 2
Aug 20, 2007
Volume 3 Number 2
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-D-26-00648 Jul 20, 2026
When less is no longer more: very early aspirin discontinuation after ACS
Piccolo R and Vitale A
free

Editorial

10.4244/EIJ-E-26-00010 Jul 20, 2026
Aspirin withdrawal after primary PCI for STEMI: timing matters
Paradies V and Mancini G
free

Editorial

10.4244/EIJ-D-26-00715 Jul 20, 2026
Endotype-guided management of ANOCA: are we ready?
Montone R
free

Original Research

10.4244/EIJ-D-26-00148 Jul 20, 2026
Endotype-guided medical therapy and symptom response in ANOCA
Farina J et al

Research Correspondence

10.4244/EIJ-D-25-01215 Jul 20, 2026
Prevalence of vasomotor dysfunction in patients with residual or recurrent angina after percutaneous coronary intervention
Crooijmans C et al

Flashlight

10.4244/EIJ-D-25-00731 Jul 20, 2026
Collapse of a new-generation magnesium scaffold
Bastante T et al
Trending articles
335.05

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
84.05

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
49.35

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
45.65

State-of-the-Art

10.4244/EIJ-D-25-01346 May 4, 2026
Slow flow and no reflow after percutaneous coronary intervention
Brugaletta S et al
free
38.2

State-of-the-Art

10.4244/EIJ-D-24-00195 Apr 7, 2025
Percutaneous coronary intervention for calcified and resistant lesions
Pesarini G et al
free
33.9

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved